CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies

Adoptive cell therapy has received a great deal of interest in the treatment of advanced cancers that are resistant to traditional therapy. The tremendous success of chimeric antigen receptor (CAR)-engineered T (CAR-T) cells in the treatment of cancer, especially hematological cancers, has exposed C...

Descripción completa

Detalles Bibliográficos
Autores principales: Marofi, Faroogh, Saleh, Marwan Mahmood, Rahman, Heshu Sulaiman, Suksatan, Wanich, Al-Gazally, Moaed E., Abdelbasset, Walid Kamal, Thangavelu, Lakshmi, Yumashev, Alexei Valerievich, Hassanzadeh, Ali, Yazdanifar, Mahboubeh, Motavalli, Roza, Pathak, Yashwant, Naimi, Adel, Baradaran, Behzad, Nikoo, Marzieh, Khiavi, Farhad Motavalli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252313/
https://www.ncbi.nlm.nih.gov/pubmed/34215336
http://dx.doi.org/10.1186/s13287-021-02462-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252313/
https://www.ncbi.nlm.nih.gov/pubmed/34215336
http://dx.doi.org/10.1186/s13287-021-02462-y

Ejemplares similares